Journal of Vaccines and Immunology Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesYes
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editorial Board

    Salvatore Chirumbolo
    Professor
    Department of Pathology and Diagnostics
    University of Verona
    Italy
    JVI

    Research Interest: Allergy test in clinical diagnosis, Immunotherapy and in vitro cell assay, Anti-inflammatory properties of natural compounds, Allergy and vaccination, Basophil activation tests.

    More Info.
    Wayne Grant Carter
    Division of Medical Sciences & Graduate Entry Medicine
    University of Nottingham
    UK
    JVI

    Research Interest: Research interests are varied and include detection and utilisation of novel biomarkers of toxicological exposure.

    More Info.
    Mahfoozur Rahman
    Associate Professor
    Department of Pharmaceutics
    Abhilashi College of Pharmacy
    India
    JVI

    Research Interest: Immune based inflammatory disorders (with special reference to nanomedicines).

    More Info.
    Rajagopal Appavu
    Department of Experimental Radiation Oncology
    University of Texas MD Anderson Cancer Center
    USA
    JVI

    Research Interest: Structural determination of protein-DNA, Solid: X-ray, Solution: 2D & 3D NMR, and Gas: Mass Spectrometry, interactions and their pathways, stability, dynamics, and function.

    More Info.
    Vassilios Lougaris
    Assistant Professor
    University of Brescia
    Italy
    JVI

    Research Interest: Interest has been in the field of immunology.

    More Info.
    Haiqi He
    Southern Plains Agricultural Research Center
    USA
    JVI
    More Info.
    Andrea Poscia
    Public Health Institute
    Catholic University of Sacred Heart of Rome
    Italy
    JVI

    Research Interest: HTA and to new communication strategies with people about vaccination, especially in consideration of the rising phenomena of anti-vaccination movements.

    More Info.
    Pele Choi-Sing Chong
    Founder of Vaccine Research and Development Center
    National Institute of Infectious Diseases and Vaccinology
    Taiwan
    JVI

    Research Interest: Protein Engineering, Adjuvant and Vaccine Delivery Systems, Vaccinology, cGMP Quality Management, Immunology.

    More Info.
    Li Junwei
    Texas Tech University
    USA
    JVI

    Research Interest: My Research Focus on Design Universal and Live Attenuated Influenza Vaccine by using Novel Methods, and Testingthese New Generation Vaccine Candidates in Humanized Mice and Ferrets. As Well, We would like to explore the Mechanism of Cross-Protection induced by live Attenuated Influenza against seasonal and Pandemic Influenza Viruses. Our Results Suggested That Activation of T cell Is Crucial for the cross Protection Stimulated By vaccination With Live Attenuated Influenza Vaccine. In Future Research, We Will Focus on B Cell Development Stimulated by Vaccination with Live Attenuated Influenza vaccine. To Facilitate The Development Of More Effective Vaccines, We Are Also Researching: The Effect Of Current Vaccination Programs On The Epidemiological Changes Of Respiratory Pathogens (Strain Replacement And Antigenic Variation); How People Respond To Infections Or Vaccinations At The Cellular And Molecular Levels (B Cell, T Cell, And Gene expression Levels) identification of New Protective Antigens Through Genomic And Proteomic Approaches.

    More Info.
    Weida Liu
    Professor
    Head, Department of Medical Mycology
    Chinese Academy of Medical Sciences
    China
    JVI

    Research Interest: Diagnosis of fungal infections; Therapy of mycoses; Pathogenesis of fungal infection; Antifungal drug resistance; Fungal infection animal model; Genomics in medical mycology; Candida mucosal immunity; Infectious dermatosis; genodermatoses.

    More Info.
    Robert Amato
    Professor and Director
    Department of Oncology
    USA
    JVI

    Research Interest: Genitourinary Cancer

    More Info.
    Jianjun Zhao
    Institute of Special Economic Animal and Plant Sciences
    Sichuan Agriculture University
    China
    JVI

    Research Interest: Veterinary Vaccine and Immunology, Veterinay Virology (Canine distemper virus, Canine parvovorus and Classical swine fever virus.

    More Info.
    Guoyun Chen
    Assistant Professor
    Department of Pediatrics
    University of Tennessee Health Science Center
    USA
    JVI

    Research Interest: Self-nonself discrimination in innate immunity, Host-pathogen interactions Autoimmune diseases.

    More Info.
    Farhid Hemmatzadeh
    Senior Lecturer in Virology
    The University of Adelaide
    Australia
    JVI

    Research Interest: Molecular epidemiology, Development of diagnostic tests for viral disease, Cell culture, Bioinformatics.

    More Info.
    Kuo C SHENG
    Research Fellow
    Griffith University
    Australia
    JVI

    Research Interest: Cancer immunology, vaccines, cancer, antigen-presenting cells and viral immunology.

    More Info.
    View more
    mendeley

    Post-vaccinal reactions following vaccination with the COVID-19 vaccine after first and second dose

    DOI Logo 10.17352/jvi.000060

    Published On: March 05, 2024 | Pages: 006 - 010

    Author(s): Velina Stoeva*, Rosen Mihaylov, Blagovesta Pencheva and Antoineta Mihova

    ORCID Logo  0000-0002-6239-4418

    Abstract View Full Article View
    mendeley

    Considerations for improving future pandemic responses

    DOI Logo 10.17352/jvi.000059

    Published On: February 08, 2024 | Pages: 001 - 005

    Author(s): Mikolaj Raszek*, David Cowley and Alberto Rubio-Casillas

    ORCID Logo  0009-0003-5755-3415

    Abstract View Full Article View
    mendeley

    Evaluation of Anti-SARS-CoV-2 IgG antibody response following COVISHEILD vaccination: A comparison between previously infected and non-infected cohorts

    DOI Logo 10.17352/jvi.000058

    Published On: August 19, 2023 | Pages: 030 - 036

    Author(s): Md Shakeel Ahmed*, Md Zakir Hossain, Md Mamunur Rashid, Istiak Ahmad, Md Zahirul Islam, Meherab Hossain and Hasan Rabbi

    ORCID Logo  0000-0002-3405-2146

    Abstract View Full Article View
    mendeley

    Dietary intervention in enhancing immunity of cancer patients

    DOI Logo 10.17352/jvi.000057

    Published On: August 09, 2023 | Pages: 024 - 029

    Author(s): Dietary intervention in enhancing immunity of cancer patients

    ORCID Logo  0000-0001-8856-3681

    Abstract View Full Article View
    mendeley

    Percutaneous Patent Ductus Arteriosus (PDA) closure: When and how to close Coil VS Occluder “step by step” cases report

    DOI Logo 10.17352/jvi.000056

    Published On: March 22, 2023 | Pages: 015 - 023

    Author(s): Nassime Zaoui*, Amina Boukabous, Nabil Irid, Katia Babou and Sabrina Benamara
    Abstract View Full Article View
    mendeley

    Study of adverse events following 2018 sub-national yellow fever vaccination in Ghana

    DOI Logo 10.17352/jvi.000055

    Published On: February 25, 2023 | Pages: 006 - 014

    Author(s): Douglas Adu-Fokuo, Feng Cheng*, Emily Yin and Elizabeth Giwa
    Abstract View Full Article View
    mendeley

    Alopecia areata

    DOI Logo 10.17352/jvi.000054

    Published On: February 21, 2023 | Pages: 001 - 005

    Author(s): Chieh Chen*

    ORCID Logo  0000-0001-5784-9855

    Abstract View Full Article View
    mendeley

    Characterization of enterotoxigenic Escherichia coli heat-labile toxin (LT) double mutant LTA72R/R192G as a Nontoxic and Effective Mucosal Adjuvant

    DOI Logo 10.17352/jvi.000053

    Published On: October 26, 2022 | Pages: 033 - 039

    Author(s): Li Ben-Qiang, Tao Jie, Cheng Jing-Hua, Shi Ying and Liu Hui-li*
    Abstract View Full Article View
    mendeley

    Effect of a third booster dose of COVID-19 mRNA vaccine in patients with haematological cancer after the initial two-dose vaccination - a single centre report

    DOI Logo 10.17352/jvi.000052

    Published On: August 08, 2022 | Pages: 029 - 032

    Author(s): Šušol Ondrej, Šušolová Barbora and Hájek Roman*
    Abstract View Full Article View
    mendeley

    Adult-onset Still’s disease complicated with macrophage activation syndrome: A case report

    DOI Logo 10.17352/jvi.000051

    Published On: July 23, 2022 | Pages: 023 - 028

    Author(s): MNSK Perera* and A Gunapala
    Abstract View Full Article View    

     

    Indexing/Archiving